News

According to the agreement, China Biopharma will distribute pharmaceutical products made by international companies including human vaccines in China using its sales network and distribution logistics. In order

The Phase I clinical trial will evaluate the safety, tolerability, pharmacokinetic and pharmacodynamic profile of MBX-2982. Investigators expect to enroll a total of 60 healthy volunteers in the

The double-blind, placebo-controlled efficacy study will involve approximately 400 patients, and will assess an intermittent dosage regimen of cetrorelix as a potential safe and tolerable treatment providing prolonged

Under the agreement, Heraeus will manufacture picoplatin active pharmaceutical ingredient (API) to meet cGMP requirements, and be ready to ship commercial quantities of picoplatin by 2009. Heraeus is

This Phase III study is a multi-center, baseline-controlled, single dose study in which approximately 250 patients will receive an unenhanced magnetic resonance imaging (MRI) followed by a secretin-enhanced

Total disposable revenues were $2.8 million versus $3.0 million in the third quarter of fiscal 2008. Disposable revenues associated with the company’s core AXP AutoXpress Platform (AXP) and

Under the new agreement, HistoRx will provide Lilly researchers broad access to the Aqua technology for tissue biomarker analysis, and HistoRx will develop customized Aqua analysis-based immunohistochemical assays

In the study, scopolamine significantly reduced vigilance levels and cognition as measured by spectral analysis and Event Related Potentials (ERPs) respectively when administered to study subjects. The results

This study is a final key step in the company’s preparations to submit an investigational new drug (IND) application to the FDA in the third quarter in order